|
Marc Pfeffer answers a few questions
about his new hot paper in the field of Clinical Medicine.
| "Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme," by
Pfeffer, MA;Swedberg, K;Granger,
CB;Held, P;McMurray, JJV;Michelson, EL;Olofsson,
B;Ostergren, J;Yusuf, S,
(LANCET, 362
759-766, SEP 6 2003).
[Authors' affiliation: 7 U.S.
institutions.] |
Why do you think your paper is highly cited?
“CHARM was designed to ascertain whether the angiotensin receptor blocker
 candesartan could reduce the incidence of cardiovascular death or need for hospitalization for management of heart failure of the broadest range of patients identified as having symptomatic heart failure in spite of optimal medical
management...”
[read
complete interview]
View
the record of Marc Pfeffer in ISIHighlyCited.com.
in-cites.com,
ESI-Topics.com, and ScienceWatch.com
are editorial components
of Essential
Science Indicators .
Read
more about them.
|
